1-1645238-CCTTTCTAA-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_033486.3(CDK11B):c.511_518delTTAGAAAG(p.Leu171fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000675 in 148,138 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0000068 ( 0 hom., cov: 22)
Consequence
CDK11B
NM_033486.3 frameshift
NM_033486.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.69
Genes affected
CDK11B (HGNC:1729): (cyclin dependent kinase 11B) This gene encodes a member of the serine/threonine protein kinase family. Members of this kinase family are known to be essential for eukaryotic cell cycle control. Due to a segmental duplication, this gene shares very high sequence identity with a neighboring gene. These two genes are frequently deleted or altered in neuroblastoma. The protein kinase encoded by this gene can be cleaved by caspases and may play a role in cell apoptosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK11B | NM_033486.3 | c.511_518delTTAGAAAG | p.Leu171fs | frameshift_variant | 6/20 | ENST00000341832.11 | NP_277021.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK11B | ENST00000341832.11 | c.511_518delTTAGAAAG | p.Leu171fs | frameshift_variant | 6/20 | 1 | NM_033486.3 | ENSP00000463048.2 |
Frequencies
GnomAD3 genomes AF: 0.00000675 AC: 1AN: 148138Hom.: 0 Cov.: 22
GnomAD3 genomes
AF:
AC:
1
AN:
148138
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00000675 AC: 1AN: 148138Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 72284
GnomAD4 genome
AF:
AC:
1
AN:
148138
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
72284
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Brachymorphism-onychodysplasia-dysphalangism syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Nov 25, 2024 | The heterozygous p.Leu171GlufsTer118 variant in CDK11B was identified by our study, in the compound heterozygous state, in 2 siblings with Brachymorphism-onychodysplasia-dysphalangism syndrome. While this gene is still lacking sufficient evidence to establish a gene-disease relationship, we believe this is a possible novel gene candidate for Brachymorphism-onychodysplasia-dysphalangism syndrome. Given the limited information about this gene-disease relationship, the significance of the p.Leu171GlufsTer118 variant is uncertain. If you have any additional information about functional evidence or other individuals with this phenotype that also have variants in CDK11B we encourage you to reach out to us. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at